ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE

Por M. G. Glezer, E. I. Astashkin, I. N. Sokolova
Publicado em 2013-10-01

Predicting post-hospital lethality in males and females with acute coronary syndrome

Por R. T. Saygitov, M. G. Glezer, D. P. Sementsov, I. N. Sokolova, N. A. Malygina
Publicado em 2006-06-01

LOCAL RECURRENCE OF TUBULOCYSTIC CARCINOMA 4 YEARS AFTER RENAL RESECTION (A CLINICAL OBSERVATION)

Por M. V. Peters, D. A. Roshchin, A. I. Karseladze, I. N. Sokolova, V. B. Matveev
Publicado em 2011-09-01

LOCAL RECURRENCE OF TUBULOCYSTIC CARCINOMA 4 YEARS AFTER RENAL RESECTION (A CLINICAL OBSERVATION)

Por M. V. Peters, D. A. Roshchin, A. I. Karseladze, I. N. Sokolova, V. B. Matveev
Publicado em 2011-09-01

Management of patients with urinary bladder cancer at T1G3 stage

Por A. D. Panakhov, K. M. Figurin, B. Sh. Kamolov, I. V. Seregin, I. N. Sokolova
Publicado em 2006-09-01

NEPHROBLASTOMATOSIS IN CHILDREN: REVIEW OF LITERATURE AND THE AUTHORS’ STUDY FINDINGS

Por T. A. Sharoyev, I. N. Sokolova, N. M. Ivanova, M. V. Rubanskaya, N. A. Koshechkina, T. R. Panferova
Publicado em 2009-12-01

Prognostic value of expression of thymidine phosphorylase, Bcl-2, and Ki-67 in renal cancer T1-2N0M0

Por S. L. Gutorov, Ye. V. Stepanova, Ya. V. Vishnevskaya, Ye. V. Chernoglazova, I. N. Sokolova, V. B. Matveev
Publicado em 2007-12-01

Prognostic factors of the therapeutic efficacy of mTOR and VEGFR inhibitors in patients with metastatic renal cell carcinoma

Por Е. А. Voroshilova, N. V. Apanovich, D. A. Nosov, А. V. Karpukhin, I. N. Sokolova, M. Yu. Fedyanin
Publicado em 2015-12-01